Literature DB >> 18154802

Tricuspid regurgitation in patients undergoing pericardiectomy for constrictive pericarditis.

Enrique Góngora1, Joseph A Dearani, Thomas A Orszulak, Hartzell V Schaff, Zhuo Li, Thoralf M Sundt.   

Abstract

BACKGROUND: Tricuspid regurgitation (TR) may complicate pericardial constriction; however, its incidence, impact on outcome, and appropriate management are not defined.
METHODS: Between January 1993 and March 2006, 481 adult patients underwent pericardiectomy at Mayo Clinic, Rochester, Minnesota. Excluding those with pericardiectomy for reasons other than constriction, previous tricuspid valve surgery, malignant infiltration, and those undergoing other concomitant cardiac operations, 261 patients remained for evaluation of echocardiographic TR before and after surgery as well as early and late survival.
RESULTS: Tricuspid regurgitation was present in 71% of patients (185 of 261); in 20% (54 of 261), TR was graded moderate or severe. Operative mortality was higher (7 of 54, 13%) among those with moderate/severe TR (7 of 54, 13%, versus 9 of 207, 4.3%; p = 0.019), and by multivariate analysis, moderate/severe TR was an independent predictor of late mortality (hazard ratio: 2.9, 95% confidence level: 1.5 to 5.6; p < 0.001). After excluding patients with prior radiation, moderate/severe TR was no longer a predictor of operative risk, but remained associated with poorer late survival (5-year survival 47% with versus 87% without). Among those with moderate/severe TR, operative mortality was similar if repair was or was not undertaken (2 of 20, 10%, versus 5 of 34, 15%; p = not significant), and late survival was not impacted. Without intervention, however, TR improved in only 29% (8 of 28).
CONCLUSIONS: Tricuspid regurgitation frequently complicates constrictive pericarditis, and when moderate or severe, is associated with increased mortality. Although valve repair has little impact on late survival, TR seldom improves with pericardiectomy alone, and may be considered to reduce symptoms, as it can be undertaken without increasing operative risk.

Entities:  

Mesh:

Year:  2008        PMID: 18154802     DOI: 10.1016/j.athoracsur.2007.06.051

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  A case of pericardial constriction: diagnosis and treatment.

Authors:  Oliva Concepción Fernández Cimadevilla; María Martín Fernández; Luis Hernández Luyando; Francisco Torres Saura
Journal:  Int J Cardiovasc Imaging       Date:  2010-05-14       Impact factor: 2.357

Review 2.  Surgery for pericardial disease.

Authors:  Yang Hyun Cho; Hartzell V Schaff
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 3.  Radical Pericardiectomy for Pericardial Diseases.

Authors:  Shinya Unai; Douglas R Johnston
Journal:  Curr Cardiol Rep       Date:  2019-02-12       Impact factor: 2.931

4.  Constrictive pericarditis treated by surgery.

Authors:  Alireza A Ghavidel; Maziar Gholampour; Majid Kyavar; Yalda Mirmesdagh; Mohammad-Bagher Tabatabaie
Journal:  Tex Heart Inst J       Date:  2012

5.  Radiation induces osteogenesis in human aortic valve interstitial cells.

Authors:  Nicole A Nadlonek; Michael J Weyant; Jessica A Yu; Joseph C Cleveland; T Brett Reece; Xianzhong Meng; David A Fullerton
Journal:  J Thorac Cardiovasc Surg       Date:  2012-09-29       Impact factor: 5.209

6.  ROVING PEN.

Authors:  Manish Hinduja
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-08-20

Review 7.  Constrictive pericarditis--a curable diastolic heart failure.

Authors:  Faisal F Syed; Hartzell V Schaff; Jae K Oh
Journal:  Nat Rev Cardiol       Date:  2014-07-29       Impact factor: 32.419

8.  Long-term results of radical pericardiectomy for constrictive pericarditis in Korean population.

Authors:  Min Suk Choi; Dong Seop Jeong; Jae K Oh; Sung-A Chang; Sung-Ji Park; Suryeun Chung
Journal:  J Cardiothorac Surg       Date:  2019-02-06       Impact factor: 1.637

9.  Surgical management of effusive constrictive pericarditis.

Authors:  Fuat Buyukbayrak; Eray Aksoy; Serpil Tas; Kaan Kirali
Journal:  Cardiovasc J Afr       Date:  2013-09-16       Impact factor: 1.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.